Riluzole treatment modestly, but significantly, reduced plasma NfL levels at both time points, a notable finding given the limited research on riluzole’s effects on NfL in preclinical or clinical ALS settings (29). Here, NEFL is linked to amyotrophic lateral sclerosis.